Inflammasomes as biomarkers and therapeutic targets in traumatic brain injury and related-neurodegenerative diseases: A comprehensive overview is a research paper published in Neuroscience & Biobehavioral Reviews (2022). On theSindex it has a DataRank of 0.483. It has been cited 24 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.483
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: 1R01GM112490-09
National Institutes of Health
Grant: 1R01GM130091-04
National Institutes of Health
Grant: 1R01NS113969-01
Role of ASC in TBI-Mediated Systemic Inflammation.
National Institutes of Health
Grant: 1RF1NS125578-01
The Importance of Abnormal Inflammasome Activation as a Risk Factor between Traumatic Brain Injury and Alzheimer’s Disease
National Institutes of Health
Grant: 1U01CA225753-05
NINDS NIH HHS
Grant: RF1 NS125578
NIGMS NIH HHS
Grant: R01 GM112490
NCI NIH HHS
Grant: U01 CA225753
NCATS NIH HHS
Grant: UL1 TR002736
NINDS NIH HHS
Grant: R01 NS113969
NIGMS NIH HHS
Grant: R01 GM130091
National Institute on Minority Health and Health Disparities
Miami Clinical and Translational Science Institute, University of Miami
National Center for Advancing Translational Sciences
FWCI
1.58
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals